| | | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2018 ( Subtotal = $0 ) |
| 2018 | 2017 | ANTICANCER, INC | 7917 OSTROW ST | SAN DIEGO | CA | 92111-3604 | SAN DIEGO | USA | R43CA213649 | Establishment of a patient-like mouse models of soft-tissue sarcoma sub-types | 000 | 1 | NIH | 5/24/2018 | $0 |
|
 | Issue Date FY: 2017 ( Subtotal = $224,700 ) |
| 2017 | 2017 | ANTICANCER, INC | 7917 OSTROW ST | SAN DIEGO | CA | 92111-3604 | SAN DIEGO | USA | R43CA213649 | Establishment of a patient-like mouse models of soft-tissue sarcoma sub-types | 000 | 1 | NIH | 12/5/2016 | $224,700 |
|
 | Issue Date FY: 2014 ( Subtotal = $449,400 ) |
| 2014 | 2014 | ANTICANCER, INC | 7917 OSTROW STREET | SAN DIEGO | CA | 92111-3604 | SAN DIEGO | USA | R43CA183280 | Pancreatic-Cancer Imageable Patient-Derived Orthotopic Xenografts (iPDOX) | 000 | 1 | NIH | 7/15/2014 | $224,700 |
| 2014 | 2014 | ANTICANCER, INC | 7917 OSTROW STREET | SAN DIEGO | CA | 92111-3604 | SAN DIEGO | USA | R43NS086217 | Hair follicle nestin-expressing stem cells on a scaffold for nerve repair | 000 | 1 | NIH | 7/16/2014 | $224,700 |
|
 | Issue Date FY: 2011 ( Subtotal = $386,199 ) |
| 2011 | 2011 | ANTICANCER, INC | 7917 OSTROW STREET | SAN DIEGO | CA | 92111-3604 | SAN DIEGO | USA | R44CA126023 | TARGETED TUMORICIDAL BACTERIA | 000 | 3 | NIH | 6/14/2011 | $386,199 |
|
 | Issue Date FY: 2010 ( Subtotal = $374,950 ) |
| 2010 | 2010 | ANTICANCER, INC | 7917 OSTROW STREET | SAN DIEGO | CA | 92111-3604 | SAN DIEGO | USA | R44CA126023 | TARGETED TUMORICIDAL BACTERIA | 000 | 2 | NIH | 5/17/2010 | $374,950 |
|
 | Issue Date FY: 2008 ( Subtotal = $149,575 ) |
| 2008 | 2008 | ANTICANCER, INC | 7917 OSTROW STREET | SAN DIEGO | CA | 92111 | SAN DIEGO | USA | R43CA132242 | ADENOVIRAL GFP TARGETING OF METASTATIC HUMAN TUMORS USING MULTIPLE DELIVERY ROUTE | 000 | 1 | NIH | 6/13/2008 | $149,575 |
|
 | Issue Date FY: 2007 ( Subtotal = $1,274,931 ) |
| 2007 | 2007 | ANTICANCER, INC | 7917 OSTROW STREET | SAN DIEGO | CA | 92111 | SAN DIEGO | USA | R43CA126023 | TARGETED TUMORICIDAL BACTERIA | 000 | 1 | NIH | 9/21/2007 | $149,799 |
| 2007 | 2007 | ANTICANCER, INC | 7917 OSTROW STREET | SAN DIEGO | CA | 92111 | SAN DIEGO | USA | R44AR050933 | THERAPEUTIC HAIR FOLLICLE-DERIVED NEUROSPHERES | 000 | 3 | NIH | 8/7/2007 | $374,500 |
| 2007 | 2007 | ANTICANCER, INC | 7917 OSTROW STREET | SAN DIEGO | CA | 92111 | SAN DIEGO | USA | R44CA103563 | DUAL-COLOR TUMOR-HOST IMAGING MODELS | 000 | 3 | NIH | 5/24/2007 | $375,784 |
| 2007 | 2007 | ANTICANCER, INC | 7917 OSTROW STREET | SAN DIEGO | CA | 92111 | SAN DIEGO | USA | R44CA099258 | ORTHOTOPIC MODELS OF TUMOR ANGIOGENESIS AND BLOOD FLOW | 000 | 3 | NIH | 9/4/2007 | $374,848 |
|
 | Issue Date FY: 2006 ( Subtotal = $1,274,932 ) |
| 2006 | 2006 | ANTICANCER, INC | 7917 OSTROW STREET | SAN DIEGO | CA | 92111 | SAN DIEGO | USA | R43CA119841 | IMAGEABLE TUMOR-TARGETING BACTERIA | 000 | 1 | NIH | 9/26/2006 | $149,800 |
| 2006 | 2006 | ANTICANCER, INC | 7917 OSTROW STREET | SAN DIEGO | CA | 92111 | SAN DIEGO | USA | R44AR050933 | THERAPEUTIC HAIR FOLLICLE-DERIVED NEUROSPHERES | 000 | 2 | NIH | 8/11/2006 | $374,500 |
| 2006 | 2006 | ANTICANCER, INC | 7917 OSTROW STREET | SAN DIEGO | CA | 92111 | SAN DIEGO | USA | R44CA103563 | DUAL-COLOR TUMOR-HOST IMAGING MODELS | 000 | 2 | NIH | 5/19/2006 | $375,784 |
| 2006 | 2006 | ANTICANCER, INC | 7917 OSTROW STREET | SAN DIEGO | CA | 92111 | SAN DIEGO | USA | R44CA099258 | ORTHOTOPIC MODELS OF TUMOR ANGIOGENESIS AND BLOOD FLOW | 000 | 2 | NIH | 9/27/2006 | $374,848 |
|
 | Issue Date FY: 2005 ( Subtotal = $299,600 ) |
| 2005 | 2005 | ANTICANCER, INC | 7917 OSTROW STREET | SAN DIEGO | CA | 92111 | SAN DIEGO | USA | R43HL074667 | ENZYME THERAPY FOR HYPERHOMOCYSTEINEMIA | 000 | 1 | NIH | 3/14/2005 | $149,800 |
| 2005 | 2005 | ANTICANCER, INC | 7917 OSTROW STREET | SAN DIEGO | CA | 92111 | SAN DIEGO | USA | R43AR050933 | THERAPEUTIC HAIR FOLLICLE-DERIVED NEUROSPHERES | 000 | 1 | NIH | 4/4/2005 | $149,800 |
|
 | Issue Date FY: 2004 ( Subtotal = $149,800 ) |
| 2004 | 2004 | ANTICANCER, INC | 7917 OSTROW STREET | SAN DIEGO | CA | 92111 | SAN DIEGO | USA | R43CA101600 | DISCOVERY OF NOVEL FLUORESCENT REPORTER GENES | 000 | 1 | NIH | 3/18/2004 | $149,800 |
|
 | Issue Date FY: 2003 ( Subtotal = $299,600 ) |
| 2003 | 2003 | ANTICANCER, INC | 7917 OSTROW STREET | SAN DIEGO | CA | 92111 | SAN DIEGO | USA | R43CA099258 | ORTHOTOPIC MODELS OF TUMOR ANGIOGENESIS AND BLOOD FLOW | 000 | 1 | NIH | | $149,800 |
| 2003 | 2003 | ANTICANCER, INC | 7917 OSTROW STREET | SAN DIEGO | CA | 92111 | SAN DIEGO | USA | R43CA103563 | DUAL-COLOR TUMOR-HOST IMAGING MODELS | 000 | 1 | NIH | 8/15/2003 | $149,800 |
|
 | Issue Date FY: 2002 ( Subtotal = $721,536 ) |
| 2002 | 2002 | ANTICANCER, INC | 7917 OSTROW STREET | SAN DIEGO | CA | 92111 | SAN DIEGO | USA | R44HL063263 | RHOMOCYCSTEINASE FOR HOMOCYSTEINE ASSAY | 000 | 3 | NIH | 9/11/2002 | $451,736 |
| 2002 | 2002 | ANTICANCER, INC | 7917 OSTROW STREET | SAN DIEGO | CA | 92111 | SAN DIEGO | USA | R43AR048724 | INHIBITORS OF 5ALPHA-REDUCTASE FOR ACNE THERAPY | 000 | 1 | NIH | 6/19/2002 | $149,800 |
| 2002 | 2002 | ANTICANCER, INC | 7917 OSTROW STREET | SAN DIEGO | CA | 92111 | SAN DIEGO | USA | R43CA089779 | GFP IMAGING FOR IN VIVO HIGH-THROUGHPUT DRUG SCREENING | 000 | 2 | NIH | 2/28/2002 | $120,000 |
|
 | Issue Date FY: 2001 ( Subtotal = $906,150 ) |
| 2001 | 2001 | ANTICANCER, INC | 7917 OSTROW STREET | SAN DIEGO | CA | 92111 | SAN DIEGO | USA | R44HL063263 | RHOMOCYCSTEINASE FOR HOMOCYSTEINE ASSAY | 000 | 2 | NIH | 9/26/2001 | $463,300 |
| 2001 | 2001 | ANTICANCER, INC | 7917 OSTROW STREET | SAN DIEGO | CA | 92111 | SAN DIEGO | USA | R43CA089779 | GFP IMAGING FOR IN VIVO HIGH-THROUGHPUT DRUG SCREENING | 000 | 1 | NIH | 3/8/2001 | $250,000 |
| 2001 | 2001 | ANTICANCER, INC | 7917 OSTROW STREET | SAN DIEGO | CA | 92111 | SAN DIEGO | USA | R43CA086166 | NEW PEGYLATED MOLECULES OF RECOMBINANT METHIONINASE | 000 | 2 | NIH | 6/21/2001 | $192,850 |
|
 | Issue Date FY: 2000 ( Subtotal = $319,420 ) |
| 2000 | 2000 | ANTICANCER, INC | 7917 OSTROW STREET | SAN DIEGO | CA | 92111-3604 | SAN DIEGO | USA | R43CA086166 | NEW PEGYLATED MOLECULES OF RECOMBINANT METHIONINASE | 000 | 1 | NIH | 6/26/2000 | $219,420 |
| 2000 | 2000 | ANTICANCER, INC | 7917 OSTROW STREET | SAN DIEGO | CA | 92111-3604 | SAN DIEGO | USA | R43CA088574 | SYNERGISTIC METHIONINASE GENE THERAPY OF CANCER | 000 | 1 | NIH | 7/17/2000 | $100,000 |
|
 | Issue Date FY: 1999 ( Subtotal = $100,000 ) |
| 1999 | 1999 | ANTICANCER, INC | 7917 OSTROW STREET | SAN DIEGO | CA | 92111-3604 | SAN DIEGO | USA | R43HL063263 | R-HOMOCYSTEINASE FOR HOMOCYSTEINE ASSAY | 000 | 1 | NIH | 4/2/1999 | $100,000 |
|
 | Issue Date FY: 1998 ( Subtotal = $331,757 ) |
| 1998 | 1998 | ANTICANCER, INC | 7917 OSTROW STREET | SAN DIEGO | CA | 92111-3604 | SAN DIEGO | USA | R44CA053963 | TUMOR IMPLANTS TO NUDE MICE FOR CANCER MODELS | 000 | 3 | NIH | 3/17/1998 | $331,757 |
|
 | Issue Date FY: 1997 ( Subtotal = $655,890 ) |
| 1997 | | ANTICANCER, INC | 7917 OSTROW STREET | SAN DIEGO | CA | 92111-3604 | SAN DIEGO | USA | R44CA57072 | LIPOSOMES FOR DELIVERY OF COMPOUNDS INTO HAIR FOLLICLES | 000 | 03 | NIH | 8/12/1997 | $355,487 |
| 1997 | | ANTICANCER, INC | 7917 OSTROW STREET | SAN DIEGO | CA | 92111-3604 | SAN DIEGO | USA | R43CA53963 | TUMOR IMPLANTS TO NUDE MICE FOR CANCER MODELS | 000 | 02 | NIH | 3/20/1997 | $300,403 |
|
 | Issue Date FY: 1996 ( Subtotal = $379,088 ) (Continued on the next page) |
|